Xtant Medical Holdings XTNT Gain (Loss) on Disposition of Stock in Subsidiary
Gain (Loss) on Disposition of Stock in Subsidiary at other companies
Other financials
Where this comes from
Reported directly by Xtant Medical Holdings in its filing.
Tagged under the XBRL concept us-gaap:GainOrLossOnSaleOfStockInSubsidiary.
The official record: Xtant Medical Holdings’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xtant Medical Holdings's gain (loss) on disposition of stock in subsidiary.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Xtant Medical Holdings's gain (loss) on disposition of stock in subsidiary?
- Xtant Medical Holdings (XTNT) reported gain (loss) on disposition of stock in subsidiary of $820.25K in Q4 2025.
- What does gain (loss) on disposition of stock in subsidiary mean?
- This metric reflects the net financial impact resulting from the divestiture or sale of equity interests in a subsidiary entity. It represents the difference between the proceeds received from the transaction and the carrying value of the investment on the company's balance sheet. This figure provides insight into the company's capital allocation strategy and its ability to unlock value through the strategic restructuring of its business portfolio.